v3.25.2
Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Information            
Revenue $ 0   $ 0   $ 10,000 $ 0
Research and development expenses 43,027   33,807   77,942 56,452
General and administrative 12,136   5,895   24,551 10,828
Stock-based compensation 6,045   1,536   11,431 2,483
Net loss to common stockholders (52,223) $ (33,573) (37,977) $ (27,800) (85,796) (65,777)
Single Reportable Segment            
Segment Information            
Revenue         10,000  
General and administrative 8,204   5,070   16,814 9,466
Stock-based compensation 6,045   1,536   11,431 2,483
Other segment items (2,940)   (1,725)   (6,697) (1,503)
Net loss to common stockholders $ (52,223)   $ (37,977)   $ (85,796) $ (65,777)
Other segment items, description Other segment items consist of other income (expense), net and income tax benefit (provision). Other income (expense), net consists of interest income and realized and unrealized gains and losses on foreign currency transactions   Other segment items consist of other income (expense), net and income tax benefit (provision). Other income (expense), net consists of interest income and realized and unrealized gains and losses on foreign currency transactions   Other segment items consist of other income (expense), net and income tax benefit (provision). Other income (expense), net consists of interest income and realized and unrealized gains and losses on foreign currency transactions Other segment items consist of other income (expense), net and income tax benefit (provision). Other income (expense), net consists of interest income and realized and unrealized gains and losses on foreign currency transactions
Single Reportable Segment | Obexelimab            
Segment Information            
Research and development expenses $ 29,894   $ 22,788   $ 53,254 $ 35,082
Single Reportable Segment | Other programs (ZB002 & ZB004)            
Segment Information            
Research and development expenses 400   572   736 1,466
Single Reportable Segment | Partnered regional programs (ZB001 & ZB005)            
Segment Information            
Research and development expenses (137)   2,435   (37) 4,023
Single Reportable Segment | Unallocated            
Segment Information            
Research and development expenses $ 10,757   $ 7,301   $ 20,295 $ 14,760